Registry of Neoplastic Meningitis in Adults

NeMeRe, a Multi-Institutional Retrospective and Prospective Registry of Neoplastic Meningitis in Adults

  • Clinical Trial Information

    Trial Contact: Manchola-Orozco, Carolina; Walton, Sherri

    Trial Phone: 321.841.7293 ; 321.841.1907

  • IRB No: 19.150.03

    Protocol Abbrev: NeMeRe

    Principal Investigator: Surabhi Ranjan, MD

    Age Group: Adult

    Secondary Protocol No: HRP-591

  • Objective

    We propose to create a comprehensive, multi-institutional retrospective and prospective electronic
    database of patients diagnosed with neoplastic meningitis from any underlying tumor histology
    (Neoplastic Meningitis Registry [NeMeRe]) with the following objectives:
    1. To define national patterns in care and gaps in treatment quality for patients with neoplastic
    meningitis.
    2. To provide longitudinal data for outcome studies.
    3. To generate hypotheses regarding the association of potential prognostic variables with outcomes in
    this patient population.
    4. To generate hypotheses regarding the association of various therapeutic interventions with outcomes
    in this patient population.
    5. To provide benchmark data for the development of quality improvement metrics.
    6. To provide information to clinicians during the treatment process to facilitate informed decision
    making by conducting quarterly review and discussion sessions with all participating investigators.

  • Key Eligibility

    All subjects 18 years of age or older, diagnosed with NM will be included. This includes retrospective
    population of subjects 18 years of age or older, who were diagnosed with and treated for NM. This may
    include decedent’s information. Retrospective data will include the timeframe 01/01/2009 to
    05/01/2015.